Alexis Wahlen, APRN
Nurse Practitioner · San Antonio, TXNPI 1194303784
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 369 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by Actelion Pharmaceuticals US, Inc. at 25.2% of the total. 2025 is the largest year on record at $4,509, 3.4 times the $1,314 reported in 2021. Among nurse practitioner clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 369 payments — averaging $42.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Actelion Pharmaceuticals US, Inc.$4K
- Merck$2K
- Alnylam Pharmaceuticals Inc.$1K
- AstraZeneca$1K
- Cvrx, Inc.$1K
- United Therapeutics Corporation$918
- plus $5K from 24 others
What the payments were for
- Food & beverage$15,24598%
- Education$3072%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 60 | $3,925 |
| Merck | 53 | $1,777 |
| Alnylam Pharmaceuticals Inc. | 36 | $1,369 |
| AstraZeneca(2 entities) | 22 | $1,095 |
| Cvrx, Inc. | 20 | $1,063 |
| United Therapeutics Corporation | 28 | $918 |
| Bayer | 16 | $718 |
| Inari Medical, Inc. | 5 | $505 |
| Abiomed | 13 | $483 |
| Novartis | 29 | $470 |
| Impulse Dynamics (USA) Inc. | 11 | $467 |
| Boehringer Ingelheim | 10 | $349 |
| E.r. Squibb & Sons, L.L.C. | 9 | $330 |
| Fresenius USA Marketing, Inc. | 2 | $317 |
| Lexicon Pharmaceuticals, Inc. | 8 | $234 |
| Daiichi Sankyo Inc. | 9 | $196 |
| Endotronix, Inc. | 1 | $186 |
| Stryker | 2 | $184 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $162 |
| Abbott | 2 | $143 |
| Pfizer | 8 | $127 |
| Boston Scientific | 2 | $118 |
| Atricure, Inc. | 1 | $88 |
| Novo Nordisk | 3 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $71 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $44 |
| Sandoz | 2 | $40 |
| GSK | 2 | $38 |
| Scpharmaceuticals Inc. | 2 | $35 |
| ANI Pharmaceuticals, Inc. | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPSUMIT$2,305
- UPTRAVI$2,201
- Barostim Neo System$841
- VERQUVO$810
- FLOWTRIEVER CATHETER, S$615
- CT THROMBECTOMY SYSTEM KIT$615
- OPTIMIZER$511
- Adempas$478
- ONPATTRO$477
- FARXIGA$250
- CAMZYOS$245
- Kerendia$238
- NOVALUNG SYSTEM$220
- CORDELLA PULOMONARY ARTERY PRESSURE SENSOR$186
- JARDIANCE$125
- AMVUTTRA$125
- WAINUA$124
- WINREVAIR$124
- TYVASO$122
- LOKELMA$121
How this compares
$15,552 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OpsumitMacitentan | 52 | $652,975 |
| VyndamaxTafamidis | 17 | $560,773 |
| EntrestoSacubitril/Valsartan | 256 | $297,487 |
| VyndaqelTafamidis Meglumine | 12 | $267,987 |
| UptraviSelexipag | 11 | $248,247 |
| OfevNintedanib Esylate | 15 | $221,631 |
| Ambrisentan | 25 | $180,860 |
| FarxigaDapagliflozin Propanediol | 151 | $156,690 |
| EliquisApixaban | 109 | $115,899 |
| CamzyosMavacamten | 13 | $107,535 |
| JardianceEmpagliflozin | 55 | $77,557 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 75 | $65,177 |
| Tadalafil | 49 | $58,671 |
| Tacrolimus | 138 | $22,505 |
| XareltoRivaroxaban | 24 | $22,173 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerVyndamax, Vyndaqel, Eliquis | $127 | $944,660138 claims |
| Actelion Pharmaceuticals US, Inc.Opsumit, Uptravi | $3,925 | $901,22263 claims |
| Boehringer IngelheimOfev, Jardiance | $349 | $299,18770 claims |
| NovartisEntresto | $470 | $297,487256 claims |
| AstraZenecaFarxiga | $1,095 | $156,690151 claims |
| E.r. Squibb & Sons, L.L.C.Camzyos | $330 | $107,53513 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $38 | $70,03887 claims |
| Novo NordiskOzempic | $73 | $20,48122 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Other nurse practitioner in San Antonio
- Corrie BerkSan Antonio$155K
- Sonja BruneSan Antonio$51K
- Laura GalvanSan Antonio$32K
- Eduardo GonzalezSan Antonio$32K
- Roberta RomeroSan Antonio$26K
- Christopher GarciaSan Antonio$21K
- Jennifer ZavalaSan Antonio$17K
- Amy RivasSan Antonio$17K
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.